𝗥𝗘𝗔𝗟-𝗪𝗢𝗥𝗟𝗗 𝗘𝗙𝗙𝗘𝗖𝗧𝗜𝗩𝗘𝗡𝗘𝗦𝗦 𝗼𝗳 𝗦𝗢𝗕𝗘𝗥𝗔𝗡𝗔 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝘀𝗰𝗵𝗲𝗺𝗲 𝗶𝗻 2–11 𝘆𝗲𝗮𝗿𝘀-𝗼𝗹𝗱 𝗖𝗛𝗜𝗟𝗗𝗥𝗘𝗡 𝗱𝘂𝗿𝗶𝗻𝗴 𝗢𝗺𝗶𝗰𝗿𝗼𝗻 𝘄𝗮𝘃𝗲 𝗶𝗻 𝗖𝘂𝗯𝗮
https://thelancet.com/journals/lanam/article/PIIS2667-193X(24)00077-2/fulltext
Amazing results !!!
2) Cuba conducted a nationwide pediatric vaccination campaign in September 2021 using the heterologous SOBERANA-02-Plus vaccine scheme (2 doses of SOBERANA-02 followed by 1 dose of SOBERANA-Plus). Over 95% of children aged 2-18 were fully vaccinated by December 2021.
3) The study evaluated the real-world effectiveness of this vaccine scheme against symptomatic COVID-19 infection and severe disease in children aged 2-11 during Cuba's Omicron wave from December 2021 to June 2022.
4) The vaccine effectiveness was estimated to be 75.3% in children aged 2 years and 83.5% in children aged 3-11 years against symptomatic infection. Effectiveness remained stable and did not decrease over the 6-month follow-up period.
5) Effectiveness against severe symptomatic disease was 100% in children aged 2 years and 94.6% in children aged 3-11 years. No child deaths from COVID-19 were reported.
6) The vaccine scheme had a good safety profile, with a low rate of adverse events. Protection conferred by the vaccine appeared to be better sustained than that reported for other vaccines during Omicron.
7) The authors hypothesize that the strong and enduring immune response induced by the conjugated SOBERANA-02 vaccine can explain its protection against Omicron variants in children.
Thanks for reading
Emmanuel (X, May 3, 2024)